GP-Act III Acquisition (GPAT) Competitors $10.08 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends GPAT vs. AGBAW, AGNCP, AGNCO, AGNCN, AGNCM, AGNCL, ANSCW, AITRR, AFJKR, and AIMBUShould you be buying GP-Act III Acquisition stock or one of its competitors? The main competitors of GP-Act III Acquisition include AGBA Group (AGBAW), AGNC Investment (AGNCP), AGNC Investment (AGNCO), AGNC Investment (AGNCN), AGNC Investment (AGNCM), AGNC Investment (AGNCL), Agriculture & Natural Solutions Acquisition (ANSCW), AI Transportation Acquisition (AITRR), Aimei Health Technology (AFJKR), and Aimfinity Investment Corp. I (AIMBU). These companies are all part of the "trading" industry. GP-Act III Acquisition vs. AGBA Group AGNC Investment AGNC Investment AGNC Investment AGNC Investment AGNC Investment Agriculture & Natural Solutions Acquisition AI Transportation Acquisition Aimei Health Technology Aimfinity Investment Corp. I GP-Act III Acquisition (NASDAQ:GPAT) and AGBA Group (NASDAQ:AGBAW) are both finance, insurance, and real estate companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, risk, institutional ownership, analyst recommendations, earnings, dividends and community ranking. Does the media favor GPAT or AGBAW? In the previous week, GP-Act III Acquisition had 2 more articles in the media than AGBA Group. MarketBeat recorded 2 mentions for GP-Act III Acquisition and 0 mentions for AGBA Group. GP-Act III Acquisition's average media sentiment score of 0.30 beat AGBA Group's score of 0.00 indicating that GP-Act III Acquisition is being referred to more favorably in the media. Company Overall Sentiment GP-Act III Acquisition Neutral AGBA Group Neutral Which has higher valuation & earnings, GPAT or AGBAW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGP-Act III AcquisitionN/AN/AN/AN/AN/AAGBA Group$38.55MN/AN/AN/AN/A Does the MarketBeat Community favor GPAT or AGBAW? GP-Act III Acquisition and AGBA Group both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformGP-Act III AcquisitionN/AN/AAGBA GroupN/AN/A Is GPAT or AGBAW more profitable? Company Net Margins Return on Equity Return on Assets GP-Act III AcquisitionN/A N/A N/A AGBA Group N/A N/A N/A SummaryGP-Act III Acquisition beats AGBA Group on 2 of the 3 factors compared between the two stocks. Ad Wide Moat ResearchTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. Get GP-Act III Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for GPAT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GPAT vs. The Competition Export to ExcelMetricGP-Act III AcquisitionInvestment Offices IndustryFinance, Insurance, And Real Estate SectorNASDAQ ExchangeMarket CapN/A$1.02M$9.64B$8.80BDividend YieldN/AN/A0.98%4.07%P/E RatioN/AN/A3.2213.60Price / SalesN/AN/A2.8287.40Price / CashN/AN/AN/A36.27Price / BookN/A2.132.136.33Net IncomeN/A-$57.64M-$57.64M$225.93M7 Day PerformanceN/A2.11%1.62%-0.96%1 Month PerformanceN/A-1.44%1.30%1.06%1 Year PerformanceN/A-2.05%9.70%26.59% GP-Act III Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GPATGP-Act III AcquisitionN/A$10.08flatN/AN/A$0.00N/A0.00N/ANews CoverageAGBAWAGBA GroupN/A$0.22+29.6%N/AN/A$0.00$38.55M0.00152Gap UpAGNCPAGNC InvestmentN/A$24.73+0.0%N/A+15.7%$0.00$1.26B0.0050News CoverageAGNCOAGNC InvestmentN/A$25.33-0.2%N/A+9.1%$0.00$1.26B0.0050AGNCNAGNC InvestmentN/A$25.73-0.1%N/A+2.0%$0.00$1.26B0.0050AGNCMAGNC InvestmentN/A$25.18+0.2%N/A+7.3%$0.00$1.26B0.0050AGNCLAGNC InvestmentN/A$25.14-0.4%N/A+18.5%$0.00$1.26B0.0050ANSCWAgriculture & Natural Solutions AcquisitionN/A$0.35+24.8%N/AN/A$0.00N/A0.00N/AAITRRAI Transportation AcquisitionN/A$0.10flatN/AN/A$0.00N/A0.00N/AAFJKRAimei Health TechnologyN/A$0.20flatN/AN/A$0.00N/A0.00N/AAIMBUAimfinity Investment Corp. IN/A$11.65flatN/A+7.6%$0.00N/A0.002 Related Companies and Tools Related Companies AGBA Group Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors AGNC Investment Competitors Agriculture & Natural Solutions Acquisition Competitors AI Transportation Acquisition Competitors Aimei Health Technology Competitors Aimfinity Investment Corp. I Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GPAT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GP-Act III Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GP-Act III Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
